UNSPSC 51161718: Pentetrazol

This classification denotes a convulsant and gaba antagonist with the molecular formula C6H10N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WM5Z385K7T, chemically known as 7,8,9,10-tetrazabicyclo(5.3.0)-8,10-decadiene but generally known as pentetrazol, which bears US NIH Compound Identifier 5917. European Medicines Agency schedules Pentetrazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09690MIG.

UNSPSC 51161718 Pentetrazol is a Commodity code that in recent state and local procurement activity covers emergency response pharmaceuticals and related health services rather than the narrow chemical compound the code name suggests. State and local governments are using this code to solicit naloxone (opioid antagonist) supplies for public health programs, as well as broader on-site pharmacy service contracts. The issuing bodies include county health departments and county government benefits administrators, reflecting dual roles in emergency preparedness and employee health plan management. Work solicited includes procurement of finished pharmaceutical products and consumables for distribution through public health initiatives, and comprehensive pharmacy service delivery including drug stocking, dispensing, formulary management, and billing administration for county employee health plans.

Seminole County, Florida and Hall County, Georgia represent the recent geographic activity in this code. Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the contract included a two-year initial term with one-year renewal option and FEMA funding with attendant federal compliance requirements. Hall County, Georgia's RFQ/P #47-010 (posted May 4, 2026, due June 4, 2026) solicited on-site pharmacy services at the county family health center clinic to serve approximately 3,005 eligible county employees, retirees, and dependents, with vendors evaluated 80% on technical qualifications and 20% on cost, and an initial one-year term beginning January 1, 2027, with four optional one-year renewals. Neither solicitation specified set-aside designations for disadvantaged enterprises.